Elena Shagisultanova, MD, PhD

home / authors / elena-shagisultanova-md-phd

Articles

Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer

Jennifer Weiss, MD;Anosheh Afghahi, MD;Elena Shagisultanova, MD, PhD;Jennifer R. Diamond, MD

October 17th 2018

An otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?

Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies

Linda Overholser, MD, MPH;Elena Shagisultanova, MD, PhD;Rachel Rabinovitch, MD;Nicole Kounalakis, MD;Jennifer Diamond, MD;Christina A. Finlayson, MD;Christine M. Fisher, MD, MPH;Peter Kabos, MD;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc;Jose Mayordomo, MD, PhD

December 15th 2016

We review available strategies for screening and risk reduction through chemoprevention or risk-reducing surgery, as well as challenges for management of breast cancer in patients with prior exposure to radiation for Hodgkin lymphoma.